Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2022 10:23 ET | Source: Parexel International LLC

Parexel’s Jim Anthony Named to 2022 PharmaVOICE 100

BOSTON and DURHAM, N.C., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
June 16, 2022 09:09 ET | Source: Parexel International LLC

Parexel Expands Patient Access to Clinical Trials Through New Community Alliance Network

BOSTON, and Durham, N.C., June 16, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the launch of its Community Alliance Network, a novel...
January 19, 2022 09:00 ET | Source: Parexel International LLC

Parexel Named 2022 Catalyst Award Winner

BOSTON, and DURHAM, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
January 11, 2022 15:30 ET | Source: Parexel International LLC

Parexel Recognized as “Top CRO” to Work With in WCG CenterWatch Global Site Relationship Benchmark Survey

BOSTON, and DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
January 11, 2022 09:00 ET | Source: Parexel International LLC

Parexel Bolsters Regulatory and Access Offering with Key Appointment

BOSTON, and Durham, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
January 06, 2022 09:00 ET | Source: Parexel International LLC

Parexel Releases Proprietary Biotech Market Research Report to Help Guide Companies on Navigating the Biotech Investment Landscape

BOSTON and DURHAM, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
November 15, 2021 17:03 ET | Source: Parexel International LLC

EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel

EQT Private Equity and Goldman Sachs Asset Management committed to supporting Parexel’s Patients-First focus, track record of clinical excellence and dedication to qualityNewly-appointed Board of...
October 20, 2021 09:00 ET | Source: Parexel International LLC

Parexel and Kyoto University Hospital Announce Strategic Alliance

BOSTON and DURHAM, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
October 04, 2021 08:00 ET | Source: Parexel International LLC

Parexel Strengthens Clinical Data and Digital Services Offering with Key Appointment

BOSTON and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
August 02, 2021 08:00 ET | Source: Parexel International LLC

Parexel’s Peyton Howell and Sofia Baig Named to 2021 PharmaVOICE 100

Parexel leaders recognized as two of the 100 most inspiring people in life sciences for their transformative efforts to drive equity and innovation across the industry BOSTON and DURHAM, N.C., Aug. ...